A. Bianchi

1.4k total citations
22 papers, 1.1k citations indexed

About

A. Bianchi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, A. Bianchi has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in A. Bianchi's work include Cancer-related Molecular Pathways (7 papers), Cancer Genomics and Diagnostics (3 papers) and Neurofibromatosis and Schwannoma Cases (3 papers). A. Bianchi is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Cancer Genomics and Diagnostics (3 papers) and Neurofibromatosis and Schwannoma Cases (3 papers). A. Bianchi collaborates with scholars based in United States, Germany and Spain. A. Bianchi's co-authors include Andres J. Klein–Szanto, C J Conti, Nikolai Kley, C. Marcelo Aldaz, Pamela A. Trail, Claudio J. Conti, Bernd R. Seizinger, Shin‐ichiro Mitsunaga, Joseph R. Testa and S.C. Jhanwar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and European Journal of Cancer.

In The Last Decade

A. Bianchi

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Bianchi United States 15 468 284 236 228 215 22 1.1k
P. Worst Germany 13 401 0.9× 358 1.3× 190 0.8× 129 0.6× 141 0.7× 20 1.1k
Koichi Rikimaru Japan 13 544 1.2× 517 1.8× 110 0.5× 92 0.4× 121 0.6× 20 1.0k
Rebecca D. Dodd United States 18 472 1.0× 194 0.7× 156 0.7× 162 0.7× 303 1.4× 40 897
Philippe Pujuguet Belgium 16 542 1.2× 446 1.6× 156 0.7× 59 0.3× 140 0.7× 22 1.1k
M Terada Japan 12 757 1.6× 365 1.3× 102 0.4× 49 0.2× 95 0.4× 15 1.0k
M. Noguchi Japan 11 672 1.4× 262 0.9× 183 0.8× 33 0.1× 105 0.5× 20 969
Patrizia Sini Austria 13 533 1.1× 194 0.7× 247 1.0× 37 0.2× 97 0.5× 21 917
Sétha Douc‐Rasy France 20 987 2.1× 528 1.9× 72 0.3× 166 0.7× 58 0.3× 38 1.4k
Mumtaz V. Rojiani United States 14 537 1.1× 169 0.6× 161 0.7× 35 0.2× 101 0.5× 29 931
Hideki Izumi Japan 17 883 1.9× 327 1.2× 412 1.7× 161 0.7× 69 0.3× 33 1.2k

Countries citing papers authored by A. Bianchi

Since Specialization
Citations

This map shows the geographic impact of A. Bianchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bianchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bianchi more than expected).

Fields of papers citing papers by A. Bianchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Bianchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bianchi. The network helps show where A. Bianchi may publish in the future.

Co-authorship network of co-authors of A. Bianchi

This figure shows the co-authorship network connecting the top 25 collaborators of A. Bianchi. A scholar is included among the top collaborators of A. Bianchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Bianchi. A. Bianchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trail, Pamela A. & A. Bianchi. (1999). Monoclonal antibody drug conjugates in the treatment of cancer. Current Opinion in Immunology. 11(5). 584–588. 71 indexed citations
2.
Trail, Pamela A., David Willner, A. Bianchi, et al.. (1999). Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin.. PubMed. 5(11). 3632–8. 32 indexed citations
3.
Bianchi, A., Shin‐ichiro Mitsunaga, Willemijn M. Klein, et al.. (1995). High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.. Proceedings of the National Academy of Sciences. 92(24). 10854–10858. 245 indexed citations
4.
Bianchi, A., Tetsuo Hara, Vijaya Ramesh, et al.. (1994). Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nature Genetics. 6(2). 185–192. 183 indexed citations
5.
Hara, T., A. Bianchi, Bernd R. Seizinger, & Nikolai Kley. (1994). Molecular cloning and characterization of alternatively spliced transcripts of the mouse neurofibromatosis 2 gene.. PubMed. 54(2). 330–5. 34 indexed citations
6.
Klein–Szanto, Andres J., Bruce Ruggeri, A. Bianchi, & Claudio J. Conti. (1993). Cellular and Molecular Changes During Mouse Skin Tumor Progression. Recent results in cancer research. 128. 193–204. 2 indexed citations
7.
Klijanienko, Jerzy, A. Bianchi, Adel K. El‐Naggar, et al.. (1993). Prad-1 gene amplification in head and neck squamous cell carcinoma. European Journal of Cancer. 29. S144–S144. 1 indexed citations
8.
Bianchi, A., Eugene M. Rinchik, & Claudio J. Conti. (1993). Reassignment of the H-ras-1 gene to the Hbb-terminus region of mouse Chromosome 7. Mammalian Genome. 4(4). 220–222. 1 indexed citations
9.
Navone, Nora M., A. Bianchi, Joe M. Angel, & Claudio J. Conti. (1992). A novel polymorphism near the mouse Int-2 locus. Mammalian Genome. 3(5). 296–297. 3 indexed citations
10.
Rinchik, Eugene M., Terry Magnuson, Gavin Kelsey, et al.. (1992). Mouse Chromosome 7. Mammalian Genome. 3(S1). S104–S120. 50 indexed citations
11.
Gimenez‐Conti, Irma, et al.. (1992). Activating mutation of the Ha‐ras gene in chemically induced tumors of the hamster cheek pouch. Molecular Carcinogenesis. 5(4). 259–263. 18 indexed citations
12.
Gimenez‐Conti, Irma, A. Bianchi, Susan M. Fischer, et al.. (1992). Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.. PubMed. 52(12). 3432–5. 28 indexed citations
13.
Aldaz, C. Marcelo, et al.. (1991). Promoter independence as a feature of most skin papillomas in SENCAR mice.. PubMed. 51(3). 1045–50. 21 indexed citations
14.
Bianchi, A., Nora M. Navone, C. Marcelo Aldaz, & C J Conti. (1991). Overlapping loss of heterozygosity by mitotic recombination on mouse chromosome 7F1-ter in skin carcinogenesis.. Proceedings of the National Academy of Sciences. 88(17). 7590–7594. 34 indexed citations
15.
Ruggeri, Bruce, Jorge Caamaño, Tamra Goodrow, et al.. (1991). Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.. PubMed. 51(24). 6615–21. 103 indexed citations
16.
Bianchi, A., Nora M. Navone, & C J Conti. (1991). Detection of loss of heterozygosity in formalin-fixed paraffin-embedded tumor specimens by the polymerase chain reaction.. PubMed. 138(2). 279–84. 42 indexed citations
17.
Maddaloni, Massimo, N. di Fonzo, M. Motto, et al.. (1990). Unstable alleles of the glossy-1 locus of maize show a light-dependent variation in the pattern of somatic reversion.. Maydica. 35(4). 409–420. 7 indexed citations
18.
Gimenez‐Conti, Irma, Dong Myung Shin, A. Bianchi, et al.. (1990). Changes in keratin expression during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis.. PubMed. 50(14). 4441–5. 46 indexed citations
19.
Gimenez‐Conti, Irma, C. Marcelo Aldaz, A. Bianchi, et al.. (1990). Early expression of type I K13 keratin in the progression of mouse skin papillomas. Carcinogenesis. 11(11). 1995–1999. 48 indexed citations
20.
Bianchi, A.. (1962). On the nature of mutations in maize.. PubMed. 51. 152–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026